Generic Name and Formulations:
Clindamycin (as phosphate) 1%, benzoyl peroxide 5%; gel.
Bausch Health Companies Inc.
Indications for BENZACLIN:
Apply twice daily.
History of regional enteritis, ulcerative or antibiotic-associated colitis.
Avoid eyes, mucous membranes, sun, UV light. Discontinue if significant diarrhea occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Lincosamide antibiotic + antibacterial/keratolytic.
Additive irritation with other topical agents. Avoid erythromycin.
Dry skin, application site reaction, pruritus, peeling, erythema, sunburn, may bleach fabrics or hair; rare: superinfection, colitis.
Jar—25g; Pump—50g; BenzaClin Care Kit—(50g BenzaClin pump + 20 ampules Viscontour Serum)
Clinical Pain Advisor Articles
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Opioids: Clinician Concern and Prescribing Practices
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Ensuring Safety During Long-Term Opioid Therapy
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain
- Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
- CDC: 8.8% of Individuals in the United States Uninsured in First Half of 2018
- Patient Experiences Shed Light on Diagnostic Errors
- Topical Migraine Trigger Point Treatment as Effective as Injection
- Wikipedia in Medical Education: An Educator's Guide to Crowdsourcing